These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14504417)

  • 1. Effects of scopolamine on matching to sample paradigm and related tests in human subjects.
    Koller G; Satzger W; Adam M; Wagner M; Kathmann N; Soyka M; Engel R
    Neuropsychobiology; 2003; 48(2):87-94. PubMed ID: 14504417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia.
    Robbins TW; Semple J; Kumar R; Truman MI; Shorter J; Ferraro A; Fox B; McKay G; Matthews K
    Psychopharmacology (Berl); 1997 Nov; 134(1):95-106. PubMed ID: 9399372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.
    Flicker C; Serby M; Ferris SH
    Psychopharmacology (Berl); 1990; 100(2):243-50. PubMed ID: 2305013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
    Mintzer MZ; Griffiths RR
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
    Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
    Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine attenuates scopolamine-induced memory impairment in humans.
    Riedel W; Hogervorst E; Leboux R; Verhey F; van Praag H; Jolles J
    Psychopharmacology (Berl); 1995 Nov; 122(2):158-68. PubMed ID: 8848531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.
    Kennedy DO; Wake G; Savelev S; Tildesley NT; Perry EK; Wesnes KA; Scholey AB
    Neuropsychopharmacology; 2003 Oct; 28(10):1871-81. PubMed ID: 12888775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic antagonist effects on executive control of attention.
    Thienel R; Kellermann T; Schall U; Voss B; Reske M; Halfter S; Sheldrick AJ; Radenbach K; Habel U; Shah NJ; Kircher T
    Int J Neuropsychopharmacol; 2009 Nov; 12(10):1307-17. PubMed ID: 19793402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopolamine-induced impairment of delayed recognition of abstract visual shapes.
    Rosier A; Cornette L; Orban GA
    Neuropsychobiology; 1998; 37(2):98-103. PubMed ID: 9566275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine Reduces Electrophysiological Indices of Distractor Suppression: Evidence from a Contingent Capture Task.
    Laube I; Matthews N; Dean AJ; O'Connell RG; Mattingley JB; Bellgrove MA
    Front Neural Circuits; 2017; 11():99. PubMed ID: 29270112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys.
    Spinelli S; Ballard T; Feldon J; Higgins GA; Pryce CR
    Neuropharmacology; 2006 Aug; 51(2):238-50. PubMed ID: 16678864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze.
    Antonova E; Parslow D; Brammer M; Simmons A; Williams S; Dawson GR; Morris R
    J Psychopharmacol; 2011 Sep; 25(9):1256-65. PubMed ID: 20823079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
    Kamboj SK; Curran HV
    Psychopharmacology (Berl); 2006 Nov; 188(4):482-8. PubMed ID: 17047934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to scopolamine in the elderly.
    Flicker C; Ferris SH; Serby M
    Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
    Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.